Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (41-50 of 493) with videos related to

Pageof 50
Sort By:
Oncology (Williston Park, N.Y.)|November 12, 2014
Prognostic and predictive markers for the new immunotherapiesKathleen M Mahoney, Michael B Atkins
Current Opinion in Cardiology|December 3, 2021
Arrhythmogenic right ventricular cardiomyopathy in the pediatric populationMitchell I Cohen, Melany B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Rapid development of hypertension by sorafenib: toxicity or target?Benjamin D Humphreys, Michael B Atkins
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1995
Regulation of cathepsin D gene expression in HL-60 cells by retinoic acid and calcitriolK B Atkins, B R Troen
Expert Opinion on Biological Therapy|April 23, 2004
Application of IL-2 and other cytokines in renal cancerDavid F McDermott, Michael B Atkins
Seminars in Oncology|October 19, 2006
Interleukin-2 therapy of metastatic renal cell carcinoma--predictors of responseDavid F McDermott, Michael B Atkins
Journal of Anatomy|June 1, 2016
The sclerotic ring of squamates: an evo-devo-eco perspectiveJade B Atkins, Tamara A Franz-Odendaal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinomaMichael B Atkins, Meredith Regan, David McDermott
Cureus|August 18, 2025
Cannabinoid Hyperemesis Syndrome Presenting as Postoperative Nausea and Vomiting in a Chronic Cannabis User: A Case ReportJustin B Atkins, Daniel Levine, Laura Shaw
Nature Reviews. Urology|February 6, 2020
Checkpoint inhibitor immunotherapy in kidney cancerWenxin Xu, Michael B Atkins, David F McDermott
Pageof 50

Showing results (41-50 of 493) with videos related to

Sort By:
Pageof 50
Oncology (Williston Park, N.Y.)|November 12, 2014
Prognostic and predictive markers for the new immunotherapiesKathleen M Mahoney, Michael B Atkins
Current Opinion in Cardiology|December 3, 2021
Arrhythmogenic right ventricular cardiomyopathy in the pediatric populationMitchell I Cohen, Melany B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Rapid development of hypertension by sorafenib: toxicity or target?Benjamin D Humphreys, Michael B Atkins
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1995
Regulation of cathepsin D gene expression in HL-60 cells by retinoic acid and calcitriolK B Atkins, B R Troen
Expert Opinion on Biological Therapy|April 23, 2004
Application of IL-2 and other cytokines in renal cancerDavid F McDermott, Michael B Atkins
Seminars in Oncology|October 19, 2006
Interleukin-2 therapy of metastatic renal cell carcinoma--predictors of responseDavid F McDermott, Michael B Atkins
Journal of Anatomy|June 1, 2016
The sclerotic ring of squamates: an evo-devo-eco perspectiveJade B Atkins, Tamara A Franz-Odendaal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinomaMichael B Atkins, Meredith Regan, David McDermott
Cureus|August 18, 2025
Cannabinoid Hyperemesis Syndrome Presenting as Postoperative Nausea and Vomiting in a Chronic Cannabis User: A Case ReportJustin B Atkins, Daniel Levine, Laura Shaw
Nature Reviews. Urology|February 6, 2020
Checkpoint inhibitor immunotherapy in kidney cancerWenxin Xu, Michael B Atkins, David F McDermott
Pageof 50